Yoichi Nakamura Selected Research

Yoichi Nakamura Research Topics

Disease

29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2003
25	Neoplasms (Cancer) 01/2023 - 03/2003
17	Asthma (Bronchial Asthma) 04/2023 - 10/2003
16	Lung Neoplasms (Lung Cancer) 12/2022 - 08/2003
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2022 - 03/2003
6	Heart Failure 01/2022 - 06/2002
6	Inflammation (Inflammations) 01/2019 - 01/2003
6	Adenocarcinoma of Lung 01/2016 - 11/2007
6	Breast Neoplasms (Breast Cancer) 03/2008 - 08/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2022 - 05/2017
5	Disease Progression 01/2022 - 06/2007
5	Hypersensitivity (Allergy) 01/2021 - 08/2002
5	Stomach Neoplasms (Stomach Cancer) 01/2018 - 10/2005
5	Adenocarcinoma 01/2016 - 10/2005
4	Chronic Obstructive Pulmonary Disease (COPD) 04/2023 - 12/2008
4	Anaphylaxis (Anaphylactic Shock) 01/2021 - 07/2006
4	Neutropenia 11/2019 - 01/2011
4	Infections 06/2007 - 01/2004
4	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 02/2005 - 11/2002
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2020
3	Neuroinflammatory Diseases 01/2021 - 11/2016
3	Adult-onset citrullinemia type 2 12/2019 - 05/2006
3	Dyspnea (Shortness of Breath) 01/2018 - 01/2017
3	Body Weight (Weight, Body) 07/2017 - 08/2002
3	Neoplasm Metastasis (Metastasis) 01/2017 - 05/2006
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2014 - 05/2008
3	Thrombosis (Thrombus) 11/2004 - 05/2002
2	Diabetes Mellitus 10/2023 - 01/2020
2	Rhinosinusitis 04/2023 - 10/2020
2	Allergic Rhinitis 04/2023 - 10/2020
2	Pericardial Effusion 12/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

12	ErbB Receptors (EGF Receptor)IBA 11/2022 - 02/2005
11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2007
11	Gefitinib (Iressa)FDA Link 01/2019 - 02/2005
10	Anti-Bacterial Agents (Antibiotics)IBA 02/2016 - 01/2004
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 08/2003
9	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2002
7	amrubicinIBA 09/2022 - 06/2009
7	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2005
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 05/2008
6	CytokinesIBA 10/2018 - 01/2004
5	PlatinumIBA 01/2023 - 10/2003
5	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 12/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2023 - 10/2020
4	AntibodiesIBA 04/2023 - 05/2009
4	Therapeutic UsesIBA 07/2022 - 05/2008
4	AntigensIBA 07/2022 - 05/2009
4	Messenger RNA (mRNA)IBA 01/2019 - 03/2003
4	Topoisomerase I InhibitorsIBA 11/2006 - 08/2003
3	Acetates (Acetic Acid Esters)FDA Link 01/2023 - 11/2016
3	Bevacizumab (Avastin)FDA Link 01/2023 - 09/2013
3	nedaplatinIBA 12/2022 - 01/2014
3	voglibose (Basen)IBA 01/2022 - 01/2020
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 01/2020
3	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2003
3	LipopolysaccharidesIBA 01/2021 - 11/2016
3	Immunoglobulin E (IgE)IBA 10/2020 - 07/2006
3	citrinIBA 12/2019 - 05/2006
3	aspartate-glutamate carrierIBA 12/2019 - 05/2006
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 03/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 12/2011
3	Interleukin-8 (Interleukin 8)IBA 01/2019 - 01/2004
3	Topotecan (Hycamtin)FDA LinkGeneric 12/2018 - 08/2003
3	Gemcitabine FDA Link 02/2016 - 05/2007
3	Indicators and Reagents (Reagents)IBA 10/2014 - 06/2007
3	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2014 - 05/2008
3	Vinorelbine (Navelbine)FDA LinkGeneric 09/2012 - 01/2008
3	SmokeIBA 05/2011 - 11/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010 - 04/2003
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2009 - 07/2004
3	Adenosine Triphosphate (ATP)IBA 09/2005 - 08/2003
3	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2005 - 08/2003
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2022
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2023 - 10/2020
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2023 - 10/2020
2	indacaterolIBA 01/2023 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 09/2013
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2023 - 01/2022
2	Pemetrexed (MTA)FDA Link 01/2023 - 11/2017
2	dupilumabIBA 01/2023 - 10/2020
2	osimertinibIBA 12/2022 - 11/2022
2	EnzymesIBA 09/2022 - 07/2005
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2006
2	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2019
2	Antigen-Antibody Complex (Immune Complex)IBA 07/2022 - 01/2017
2	SodiumIBA 01/2022 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 04/2023 - 03/2003
13	Therapeutics 12/2022 - 01/2004
8	Radiotherapy 01/2021 - 08/2007
4	Gastrectomy 01/2018 - 10/2006
4	Immunotherapy 01/2018 - 05/2009
3	Chemoradiotherapy 01/2021 - 11/2017
3	Laparoscopic Cholecystectomy 12/2014 - 01/2009
3	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 04/2003
2	Bronchial Thermoplasty 04/2023 - 10/2020
2	Induction Chemotherapy 01/2023 - 01/2008
2	Aftercare (After-Treatment) 01/2023 - 06/2002
2	Nebulizers and Vaporizers (Inhaler) 01/2022 - 01/2021